个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Evaluating the efficacy and safety of pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter, retrospective study analysis

| 认领 | 导出 | |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Hu, M.[1] * ; Chen, C.[2] ; Wang, Y.[3] ; Zhang, S.[4] ; Han, Y.[5] ; Wu, H.[6,8] ; Gao, J.[7] ; Lin, Q.[9] ; Shang, W.[10] ; Li, X.[11] ; Feng, H.[12] ; Qiao, Q.[13] ; Hu, G.[14] ; Yang, K.[15] ; Song, X.[16] ; Cao, D.[17] ; Kang, M.[18] ; Wang, R.[19] ; Yu, J.[20] ;
机构： [1]Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China [2]Sun Yat sen Univ, Canc Ctr, Dept Radiat Oncol, State Key Lab Oncol South China, Guangzhou, Peoples R China [3]Chongqing Canc Hosp, Dept Radiat Oncol, Chongqing, Peoples R China [4]UESTC, Sichuan Canc Hosp & Inst, Affiliated Canc Hosp, Dept Radiat Oncol,Sch Med, Chengdu, Peoples R China [5]Hunan Canc Hosp, Dept Radiat Oncol, Changsha, Peoples R China [6]Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Radiat Oncol, Zhengzhou, Peoples R China [7]Univ Sci & Technol China, Affiliated Hosp 1, Anhui Prov Hosp, Dept Radiat Oncol, Hefei, Peoples R China [8]Cent South Univ, Xiangya Hosp, Dept Oncol, Changsha, Peoples R China [9]Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen, Peoples R China [10]Qingdao Univ, Affiliated Hosp, Dept Oral & Maxillofacial Surg, Qingdao, Peoples R China [11]Liaoning Canc Hosp & Inst, Dept Head & Neck Radiotherapy, Shenyang, Peoples R China [12]Shandong First Med Univ, Shandong Prov Hosp, Canc Ctr, Jinan, Peoples R China [13]China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Liaoning, Peoples R China [14]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Oncol Dept, Wuhan, Peoples R China [15]Huazhong Univ Sci & Technol, Oncol Dept, Tongji Med Coll, Tongji Med Coll,Union Hosp, Wuhan, Peoples R China [16]Yantai Yuhunagding Hosp, Dept Otorhinolaryngol, Yantai, Peoples R China [17]Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China [18]Guangxi Med Univ, Affiliated Hosp 1, Dept Radiat Oncol, Nanning, Peoples R China [19]Xinjiang Med Univ, Affiliated Tumor Hosp, Dept Head & Neck Canc Radiotherapy, Urumqi, Peoples R China [20]Shandong Univ, Shandong Canc Hosp, Radiat Oncol Dept, Jinan, Peoples R China
出处：
DOI： 10.1016/j.annonc.2024.10.470
ISSN：

摘要：
Background: KN-048 lacks data on the Chinese population, and also there is limited information regarding the use of pembrolizumab in locally curable R/M HNSCC. This study aims to investigate the efficacy and safety of pembrolizumab in two populations.

语种：
外文
WOS：
中科院(CAS)分区：
出版当年[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2025]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2024]版：
无
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2023版]

第一作者：
第一作者机构： [1]Shandong Canc Hosp & Inst, Dept Radiat Oncol, Jinan, Peoples R China
推荐引用方式(GB/T 7714)：
Hu M.,Chen C.,Wang Y.,et al.Evaluating the efficacy and safety of pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter, retrospective study analysis[J].ANNALS OF ONCOLOGY.2024,35:doi:10.1016/j.annonc.2024.10.470.
APA：
Hu, M.,Chen, C.,Wang, Y.,Zhang, S.,Han, Y....&Yu, J..(2024).Evaluating the efficacy and safety of pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter, retrospective study analysis.ANNALS OF ONCOLOGY,35,
MLA：
Hu, M.,et al."Evaluating the efficacy and safety of pembrolizumab in recurrent or metastatic head and neck squamous cell carcinoma: A multicenter, retrospective study analysis".ANNALS OF ONCOLOGY 35.(2024)

资源点击量：58172 今日访问量：0 总访问量：4811 更新日期：2025-05-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号